Work Starts on Belgiums First Proton Therapy Center

first_img News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  May 5, 2017 — IBA announced that building works have begun on the Proton Therapy Center ParTICLe – Belgium’s first center for proton therapy. ParTICLe, short for Particle Therapy Interuniversity Center Leuven, is a clinical and scientific collaboration between five university hospitals.Currently, Belgian patients eligible for proton therapy have to travel abroad for treatment; usually to Germany, Switzerland or France. It is expected that Belgian patients will now be able to receive proton therapy in their home country by mid-2019.The new center will utilize IBA’s Proteus One compact intensity modulated proton therapy (IMPT) system, which is smaller, more affordable, and easier to install and operate.Prof. Karin Haustermans, head of the Department of Radiation Oncology in UZ Leuven, said “Despite the enormous technical advances in radiation for cancer treatment, we still see too many patients who relapse or have permanent side effects. Sometimes when healthy radiation-sensitive tissues are too close to the tumor; it is almost impossible to irradiate them without compromising the quality of life of the patient. Proton therapy provides more protection to healthy tissue, and reduces the risk of secondary cancer caused by the radiation itself.”For more information: www.iba-worldwide.com FacebookTwitterLinkedInPrint分享 News | Proton Therapy | May 05, 2017 Work Starts on Belgium’s First Proton Therapy Center Proton Therapy Center ParTICLe in Leuven will feature IBA’s Proteus One system News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more Related Content Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more Catalyst PT image courtesy of C-RAD Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read morelast_img

Leave your comment